These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1119 related articles for article (PubMed ID: 33751184)

  • 21. Proton pump inhibitor use for 12 months is not associated with changes in serum magnesium levels: a prospective open label comparative study.
    Bahtiri E; Islami H; Hoxha R; Gashi A; Thaçi K; Karakulak Ç; Thaçi S; Qorraj Bytyqi H
    Turk J Gastroenterol; 2017 Mar; 28(2):104-109. PubMed ID: 28082254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proton Pump Inhibitor Use and Magnesium Concentrations in Hemodialysis Patients: A Cross-Sectional Study.
    Nakashima A; Ohkido I; Yokoyama K; Mafune A; Urashima M; Yokoo T
    PLoS One; 2015; 10(11):e0143656. PubMed ID: 26618538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of proton pump inhibitors on Magnesium levels in Type II diabetic patients: a single centre study from Saudi Arabia.
    Lateef Junaid MA; Faraz A; Vaseem M; Salih IMA; Kutbi HAH; Al Julifi MZ; Alfhaid FM; Sami W
    Eur Rev Med Pharmacol Sci; 2023 Feb; 27(3):1077-1082. PubMed ID: 36808355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of proton pump inhibitor-induced hypomagnesemia.
    Gommers LMM; Hoenderop JGJ; de Baaij JHF
    Acta Physiol (Oxf); 2022 Aug; 235(4):e13846. PubMed ID: 35652564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and risk factors of long-term proton pump inhibitors-associated hypomagnesemia: a cross-sectional study in hospitalized patients.
    Recart DA; Ferraris A; Petriglieri CI; Alonso Serena M; Bonella MB; Posadas-Martinez ML
    Intern Emerg Med; 2021 Apr; 16(3):711-717. PubMed ID: 33001349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proton pump inhibitors linked to hypomagnesemia: a systematic review and meta-analysis of observational studies.
    Cheungpasitporn W; Thongprayoon C; Kittanamongkolchai W; Srivali N; Edmonds PJ; Ungprasert P; O'Corragain OA; Korpaisarn S; Erickson SB
    Ren Fail; 2015 Aug; 37(7):1237-41. PubMed ID: 26108134
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Perils and pitfalls of long-term effects of proton pump inhibitors.
    Wilhelm SM; Rjater RG; Kale-Pradhan PB
    Expert Rev Clin Pharmacol; 2013 Jul; 6(4):443-51. PubMed ID: 23927671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relative efficacies of gastric proton-pump inhibitors on a milligram basis: desired and undesired SH reactions. Impact of chirality.
    Kromer W
    Scand J Gastroenterol Suppl; 2001; (234):3-9. PubMed ID: 11768559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Time-Varying Use of Proton Pump Inhibitors and Cognitive Impairment and Dementia: A Real-World Analysis from Germany.
    Ahn N; Wawro N; Baumeister SE; Nolde M; Gerlach R; Tauscher M; Günter A; Güntner F; Rückert-Eheberg IM; Meisinger C; Linseisen J
    Drugs Aging; 2023 Jul; 40(7):653-663. PubMed ID: 37178361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of Antioxidant Effects of the Proton Pump-Inhibiting Drugs Omeprazole, Esomeprazole, Lansoprazole, Pantoprazole, and Rabeprazole.
    Abed MN; Alassaf FA; Jasim MHM; Alfahad M; Qazzaz ME
    Pharmacology; 2020; 105(11-12):645-651. PubMed ID: 32289807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Very Rare Side Effect of a Very Commonly Used Drug: Pantoprazole-induced Seizure.
    Anandan S; Rajendran SS; Somarajan SA; Udayan A
    J Assoc Physicians India; 2024 Aug; 72(8):89. PubMed ID: 39163076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proton Pump Inhibitor Prophylaxis After Gastric Bypass Does Not Cause Hypomagnesemia.
    Boerlage TC; van Hees CL; Huitema AD; Lauw FN
    Obes Surg; 2016 Mar; 26(3):688-90. PubMed ID: 26762281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Association between the Use of Proton Pump Inhibitors and the Risk of Hypomagnesemia in a National Cohort of Veteran Patients with HIV.
    Sutton SS; Magagnoli J; Cummings T; Hardin JW
    J Int Assoc Provid AIDS Care; 2019; 18():2325958218821652. PubMed ID: 30798693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The association of proton pump inhibitors and hypomagnesemia in the community setting.
    Markovits N; Loebstein R; Halkin H; Bialik M; Landes-Westerman J; Lomnicky J; Kurnik D
    J Clin Pharmacol; 2014 Aug; 54(8):889-95. PubMed ID: 24771616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities.
    Li XQ; Andersson TB; Ahlström M; Weidolf L
    Drug Metab Dispos; 2004 Aug; 32(8):821-7. PubMed ID: 15258107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proton-pump inhibitor use is associated with low serum magnesium concentrations.
    Danziger J; William JH; Scott DJ; Lee J; Lehman LW; Mark RG; Howell MD; Celi LA; Mukamal KJ
    Kidney Int; 2013 Apr; 83(4):692-9. PubMed ID: 23325090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low gut microbiota diversity and dietary magnesium intake are associated with the development of PPI-induced hypomagnesemia.
    Gommers LMM; Ederveen THA; van der Wijst J; Overmars-Bos C; Kortman GAM; Boekhorst J; Bindels RJM; de Baaij JHF; Hoenderop JGJ
    FASEB J; 2019 Oct; 33(10):11235-11246. PubMed ID: 31299175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Common single nucleotide polymorphisms in transient receptor potential melastatin type 6 increase the risk for proton pump inhibitor-induced hypomagnesemia: a case-control study.
    Hess MW; de Baaij JH; Broekman MM; Bisseling TM; Haarhuis BJ; Tan AC; Te Morsche RH; Hoenderop JG; Bindels RJ; Drenth JP
    Pharmacogenet Genomics; 2017 Mar; 27(3):83-88. PubMed ID: 27926584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of omeprazole, lansoprazole, pantoprazole, and rabeprazole in the treatment of acid-related diseases.
    Welage LS; Berardi RR
    J Am Pharm Assoc (Wash); 2000; 40(1):52-62; quiz 121-3. PubMed ID: 10665250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of rabeprazole, a new proton pump inhibitor, in triple therapy for Helicobacter pylori infection-comparison with omeprazole and lansoprazole.
    Miwa H; Ohkura R; Murai T; Sato K; Nagahara A; Hirai S; Watanabe S; Sato N
    Aliment Pharmacol Ther; 1999 Jun; 13(6):741-6. PubMed ID: 10383502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 56.